CRB2 enhances malignancy of glioblastoma via activation of the NF-κB pathway.
Wang Y, Bao G, Zhang M, Xiang J, Zhou H, Wahafu A, Wu W, Ma X, Huo L, Bai X, Xie W, Liu P, Wang M.
Wang Y, et al.
Exp Cell Res. 2022 May 1;414(1):113077. doi: 10.1016/j.yexcr.2022.113077. Epub 2022 Feb 25.
Exp Cell Res. 2022.
PMID: 35219647